-
Lack of diversity in Parkinson’s disease genetic research: current landscape and future directions
-
Lance-Adams Syndrome: A case series in El Salvador
-
Language impairment in Corticobasal Syndrome: from clinical phenotype to biomarkers
-
Laryngeal Electromyography Findings in patients with Multiple System Atrophy
-
Late-onset chorea in the setting of cerebrovascular disease
-
Late-onset Familial Segmental Dystonia with Novel GNAL Mutation
-
Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease; role for cholinergic transmission?
-
Lateralized Tau Pathology in a Case of Lewy Body Dementia with Corticobasal Syndrome
-
Leg muscle contractions compensate for declining cardiac baroreflex in PD Patients
-
Levodopa responsive gait dynamics in ON- and OFF-state freezing of gait in Parkinson’s disease
-
Levodopa-Carbidopa Intestinal Gel Therapy for Advanced Parkinson’s Disease: A Single Center ‘Real World’ Study of Patients with and without DBS
-
Levodopa/carbidopa intestinal gel (LCIG) reduces fluctuations and shortens time to on without troublesome dyskinesia in advanced Parkinson’s Disease: Post-hoc analyses of 54-week LCIG-monotherapy trial
-
LFP spectral features associated with therapy complications in typical and early onset Parkinson’s disease
-
Life Satisfaction and Adaptation in Persons with Parkinson’s Disease
-
Limitations of conventional dopaminergic medication in advanced Parkinson’s disease: results from 127 patients treated with Levodopa Carbidopa Intestinal Gel
-
Lingual myoclonus associated with brain metastasis located near the primary tongue motor cortex: case report.
-
Links between Cognitive Impairment and Contrast Sensitivity in Parkinson’s Disease
-
LIPAD (LRRK2/Luebeck) International Parkinson’s Disease Study: Protocol and feasibility study
-
Lipid metabolism alterations in the lysosomal membrane promotes chaperone-mediated autophagy dysfunction and alpha-synuclein pathology in Parkinson’s disease associated to GBA
-
Living with dystonia during first-wave of COVID-19 pandemic: a Framework Analysis of Open-Ended Survey Questions
-
Local Field Potentials (LFP) used to guide treatment of biphasic dyskinesias in a patient with Parkinson’s Disease (PD)
-
Locus coeruleus degeneration associated with less levodopa responsiveness in Parkinson’s Disease
-
Locus coeruleus volume is reduced in Parkinson disease-related orthostatic hypotension.
-
Long term follow-up of Wilson disease patients in Poland. Report from the national reference centre.
-
Long-term clinical outcome of deep brain stimulation in pantothenate kinase-associated neurodegeneration: a retrospective observational study
-
Long-term cognitive and motor decline across the spectrum of Lewy body disease.
-
Long-term effect of safinamide on primary motor cortex excitability and plasticity in Parkinson’s disease: a TMS study
-
Long-Term Evaluation of Deep Brain Stimulation for Treatment of Parkinson’s Disease Using a Multiple-Source, Constant-Current Rechargeable System: 4-year Follow-Up of a Prospective, Double-Blind RCT
-
Long-Term Motor Function and Quality of Life Outcomes from a Prospective, International DBS Registry
-
Long-term real-world effectiveness of carbidopa/levodopa enteral suspension after 36 months of treatment initiation: Final results from PROviDE study
-
Long-term safety and activity of ecopipam (ECO), a selective D1 antagonist during treatment of pediatric patients with Tourette Syndrome
-
Long-Term Safety and Efficacy of Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease
-
Long-Term Safety and Efficacy of Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Europe vs North America
-
Longitudinal 18F-PBR06 (TSPO) and Volumetric MR Imaging as Pharmacodynamic Endpoints for MSA – Ongoing Investigator Sponsored Trial of Verdiperstat
-
Longitudinal change in thalamic white matter macrostructure and volume in Parkinson’s disease depression
-
Longitudinal changes in nigral neuromelanin in early, levodopa-treated Parkinson’s disease
-
Longitudinal changes of gait parameters in early Parkinson’s disease
-
Longitudinal healthcare utilization and costs in Parkinson disease : from pre-diagnosis to 9 years
-
Longitudinal Speech Changes In PD and the Relationship to Limb Bradykinesia and Rigidity
-
Longitudinal structural and functional brain alterations in Parkinson’s disease patients with freezing of gait
-
Longitudinal Study of Grey Matter Nuclei in Early Parkinson’s Disease using Diffusion Kurtosis Imaging
-
LOSS OF SPIRAL AXIS FOR DIAGNOSES OF FUNCTIONAL TREMOR
-
Low dose trihexyphenidyl use causes cognitive dysfunction in Parkinson’s disease patients.
-
Low Frequency Oscillations at Limbic GPi during pre-tic activity seems associated with premonitory urges in Tourette Syndrome
-
LRRK2 Inhibition by BIIB122 / DNL151: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Ph 1 Healthy Volunteer and Ph 1B Parkinson’s Disease Trials
-
LY-487,379 alleviates parkinsonism when administered as monotherapy in the MPTP-lesioned marmoset
-
LY-487,379 enhances the anti-parkinsonian action of a low dose of L-DOPA in the MPTP-lesioned marmoset
-
Lysosomal storage disorder genes variants in Parkinson’s disease: a large cohort study in Chinese mainland population
MDS Virtual Congress 2021
September 17-22, 2021. Virtual Congress. www.mdscongress.org